REVOPSIS THERAPEUTICS, INC.
Therapeutic molecules for treating age-related macular degeneration and retinal neovascularization diseases
- Sector
- Biotech
- Headquarters
- SPRINGFIELD, IL
- Founded
- 2022
- Latest Form D
- $575K, Nov 2024
- Total capital
- $10.4M
- Federal grants
- $1.9M
- 2 awards · 2024–2025
- Rank in peer group#78 of 326
- Private capital raised
- $8.6M
- 4 Form D · last Nov 2024
- 24 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 10 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Transformational next generation high affinity trispecific fab protein to address unmet needs in Ophthalmology$934K
- Private capital raisedForm D · SEC · 4th filing$575K
- Federal grantHealth and Human S · Phase II · Transformational next generation high affinity trispecific fab protein to address unmet needs in Ophthalmology$934K
- Private capital raisedForm D · SEC · 3rd filing$7.9M
- Private capital raisedForm D · SEC · 2nd filing$100K
- Offering registeredForm D · SEC · 1st filing$521K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grants#78 · top 24%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Jeff P OlsonDirectorNamed in SEC Form D filings
- Ramanath BhandariExecutive Officer, DirectorNamed in SEC Form D filings
- Ram PalankiExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 10- PendingANG-2/VEGF Antibodies And Uses ThereofUSPTOApplication 19013495
- PendingConjugates Of Surrogate Light Chain ConstructsUSPTOApplication 19000338
- PendingConjugates Of Surrogate Light Chain ConstructsUSPTOApplication 16158377
Show all 10 patent records
- ANG-2/VEGF Antibodies And Uses ThereofAug 7, 2025 · Application 19013495Pending
- Conjugates Of Surrogate Light Chain ConstructsApr 24, 2025 · Application 19000338Pending
- Conjugates Of Surrogate Light Chain ConstructsMay 2, 2019 · Application 16158377Pending
- Compostions Of Multispecific Antigen Binding Polypeptides And Methods Of UseApplication PCTUS2024049655Pending
- Compostions Of Multispecific Antigen Binding Polypeptides And Methods Of UseApplication 63667432Pending
- Compositions Of Multispecific Antigen Binding Polypeptides And Methods Of UseApplication 63642534Pending
- Compositions Of Multispecific Antigen Binding Polypeptides And Methods Of UseApplication 63608015Pending
- Compostions Of Multispecific Antigen Binding Polypeptides And Methods Of UseApplication 63587623Pending
- ANG-2/VEGF Antibodies And Uses ThereofApplication PCTUS2023069962Pending
- Vegf-a/complement C5 Bispecific Antibodies And Methods Of Use ThereofApplication 63737378Pending
Related companies, and why
- Reservoir Neuroscience, Inc.Similar federal contract value in Biotech · null in contracts
- Carmot Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- IGM BiosciencesSimilar federal contract value in Biotech · null in contracts
- Elevian, Inc.Similar federal contract value in Biotech · null in contracts
- Momentum Superior Holdings, Inc.Similar federal contract value in Biotech · null in contracts
- Viridian TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .